Industry News
Bioniche picks US distributor for Immunocidin
Bioniche (ASX:BNC) has selected an exclusive US distributor for canine cancer product Immunocidin, which launched in the market last month. [ + ]
Bioinformatics needs support from govt and institutions: Victoria Prize winner
Professor Terry Speed says the government funding bodies and research institutions need to do more to offer a clear and stable career path for new bioinformaticians. [ + ]
Alchemia reaps $1.5m from anticoagulant in Q3
Alchemia (ASX:ACL) will receive $1.5m for the September quarter – its first proper share of the profits from sales of anticoagulant generic fondaparinux. [ + ]
Doors open at Walter and Eliza Hall upgraded $185m facility
Personalised medicine, translational research, a blood donor register and insectary for researching malaria are all part of an upgraded WEHI facility opened today. [ + ]
Research Australia Awards 2012
The Australian health and medical research community gathered to recognised its best and brightest at the Research Australia Awards for 2012. [ + ]
Institute continues pioneering medical research with $185m redevelopment
The new redeveloped Walter and Eliza Hall Institute (WEHI) of Medical Research was officially opened today. The WEHI research facility, in Parkville, Victoria, will accommodate the institute’s rapidly expanding research programs in cancer, infectious disease and chronic inflammatory disease. [ + ]
Flower power to purge poison and produce platinum
A consortium of researchers is to embark on a £3 million research program which will use a common class of flower to restore poisoned soils while at the same time producing perfectly sized and shaped nanosized platinum and arsenic nanoparticles for use in catalytic convertors, cancer treatments and a range of other applications. [ + ]
Sunshine Heart gets FDA tick for C-Pulse trial
Sunshine Heart (ASX:SHC) is set to commence a North American trial of its C-Pulse Heart Assist System, after receiving regulatory approval from the FDA. [ + ]
FDA clears AtCor blood pressure tool in US
AtCor Medical (ASX:ACG) has received FDA approval to market SphygmoCor XCEL, its upgraded cardiovascular diagnostics tool, in the US. [ + ]
Comment: Finding an alliance partner that will maximise the value of your assets
Marcus Bain, Managing Director of Wescadia Group gives a checklist for biotechnology companies of what to look for in a potential industry partner. [ + ]
Beat jetlag and sleep problems with new Australian invention
A new invention from Flinders University scientists can help reset the body clock, beat jetlag and allows shift workers to remain more alert and get more sleep. [ + ]
New Chief for CSIRO Land and Water
Australia’s environmental research will be significantly boosted by today’s appointment of internationally renowned scientist Professor Paul Bertsch as new Chief of CSIRO Land and Water. [ + ]
Waters selects MTM Research Center at Örebro University for Center of Innovation Honors
At a ceremony at the School of Science and Technology at Örebro University, Sweden, Waters has announced the selection of the MTM Research Center for its Centers of Innovation Program for research in the field of persistent organic pollutants (POPs) now regulated under provisions of the Stockholm Convention. [ + ]
Sirtex up on news of planned $4.5m manufacturing plant in Germany
Sirtex Medical (ASX:SRX) will invest $4.5m to build a manufacturing plant in Germany for its SIR-Spheres liver cancer treatments. [ + ]
Mesoblast gets go-ahead from FDA to manufacture stem cells
Mesoblast (ASX:MSB) and the US FDA have reached an agreement covering the company's manufacturing process for adult stem cells to be used in phase III trials. [ + ]
